A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma

CONCLUSION: This study underscores the importance of considering patient characteristics before administering ibrutinib as salvage therapy. Early relapse was associated with poor outcomes, highlighting the need for novel therapeutic strategies.PMID:38151961 | PMC:PMC10758639 | DOI:10.5045/br.2023.2023208

Source: Blood Research - December 28, 2023 Category: Hematology Authors: Yong-Pyo Lee Ye Ji Jung Junhun Cho Young Hyeh Ko Won Seog Kim Seok Jin Kim Sang Eun Yoon Source Type: research